Literature DB >> 33599437

β-cell self-destruction and extremely complicated and still unknown etiopathogenesis of type 1 diabetes.

Artur Chwalba1, Aleksandra Pilśniak2, Ewa Otto-Buczkowska3.   

Abstract

Type 1 diabetes is based on apoptosis, which leads to b-cell death. Factors triggering apoptosis processes are very diverse and currently not fully explained. The main role is attributed to genetic and environmental factors. Genetic studies have shown that the inherited propensity for type 1 diabetes is multi-genetic. Environmental factors modify the response to their own antigens, but are probably not necessary to start the autoaggression process. The effect of b-cell destruction is confirmed by the appearance of autoantibodies in the blood. The paper presents a review of the available literature regarding the self-destruction of pancreatic b-cells. The aim of the study was to draw attention to the extremely complicated and still unknown etiopathogenesis of type 1 diabetes by reviewing current literature related to the above topic. The goal is to acquire the knowledge necessary to develop and implement causal treatment for diabetes. At the moment, unfortunately, we do not have safe, innovative therapy methods in the field of diabetes prevention. Intensive research on the etiopathogenesis of type 1 diabetes is an extremely important field of medical research.

Entities:  

Keywords:  autoantibodies; b-cell destruction; immunological markers.; type 1 diabetes; apoptosis

Year:  2021        PMID: 33599437     DOI: 10.5114/pedm.2020.103058

Source DB:  PubMed          Journal:  Pediatr Endocrinol Diabetes Metab        ISSN: 2083-8441


  2 in total

1.  Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice.

Authors:  Ruifeng Mao; Menglan Yang; Rui Yang; Yingying Chen; Enjie Diao; Tong Zhang; Dengchao Li; Xin Chang; Zhenjing Chi; Yefu Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

2.  Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity.

Authors:  Andrea Arena; Eugenia Belcastro; Francesca Ceccacci; Stefania Petrini; Libenzio Adrian Conti; Olivia Pagliarosi; Ezio Giorda; Simona Sennato; Riccardo Schiaffini; Peng Wang; James C Paulson; Giovanna Mancini; Alessandra Fierabracci
Journal:  Front Immunol       Date:  2022-03-09       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.